Changzhou fangyuan pharmaceutical co ltd has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are JANSSEN PRODUCTS LP, POLYNEURON PHARMACEUTICALS AG and NUCLEIC ACID RESEARCH INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds | |
#5 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Yang Daria | 16 |
#2 | Wang Haidong | 15 |
#3 | Wang Huijuan | 14 |
#4 | Liew Siong Tern | 8 |
#5 | Liu Xin | 7 |
#6 | Wang Hui-Juan | 2 |
Publication | Filing date | Title |
---|---|---|
US2019256545A1 | Type of taxane compound, preparation method and application thereof | |
WO2016078399A1 | New type of cytidine derivative dimer and application thereof | |
WO2016078397A1 | New type of cytidine derivative and application thereof | |
WO2016078163A1 | New type of cytidine derivative dimer and application thereof | |
WO2016078160A1 | Cytidine derivative and application thereof |